A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Clinical trial NCT07333183 · RECRUITING

Trial details

NCT number: NCT07333183
Sponsor: Pulmovant, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Hypertension Interstitial Lung Disease (ILD)Lung Diseases Vascular Diseases Cardiovascular Diseases Fibrosis

Start date: 2025-12-23
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.